Fate Therapeutics, Inc.
Fate Therapeutics, Inc. (FATE) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · FATE · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
6
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Fate Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
FATE insider buying and selling by quarter
FATE insider selling · FATE insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · FATE ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
FATE executive sell shares · FATE board member insider trading · FATE insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 20, 2026 | TAHL CINDY See Remarks | Sale | 25,590 | $48K | Form 4 |
| May 20, 2026 | Valamehr Bahram President and CEO · Director | Sale | 28,946 | $54K | Form 4 |
| May 6, 2026 | TAHL CINDY See Remarks | Option | 44,444 | $47K | Form 4 |
| May 6, 2026 | TAHL CINDY See Remarks | Option | 122,220 | $161K | Form 4 |
| May 5, 2026 | EPSTEIN ROBERT S Director | Option | 25,000 | $42K | Form 4 |
| May 5, 2026 | RASTETTER WILLIAM H Director | Option | 25,000 | $42K | Form 4 |
| Apr 20, 2026 | Redmile Group, LLC Director | Other | 8,977,624 | — | Form 4 |
| Apr 20, 2026 | Redmile Group, LLC Director | Other | 8,977,624 | — | Form 4 |
| Jan 15, 2026 | TAHL CINDY See Remarks | Award | 100,000 | — | Form 4 |
| Jan 15, 2026 | Adawi Kamal CFO | Award | 25,000 | — | Form 4 |
| Jan 15, 2026 | Valamehr Bahram President and CEO · Director | Award | 335,000 | — | Form 4 |
| Jan 9, 2026 | TAHL CINDY See Remarks | Sale | 10,589 | $11K | Form 4 |
| Jan 9, 2026 | Valamehr Bahram President and CEO · Director | Sale | 5,190 | $6K | Form 4 |
| Oct 20, 2025 | Adawi Kamal CFO | Award | 75,000 | — | Form 4 |
| Aug 4, 2025 | TAHL CINDY See Remarks | Sale | 9,037 | $10K | Form 4 |
| Aug 4, 2025 | Valamehr Bahram President and CEO · Director | Sale | 14,466 | $15K | Form 4 |
| Jan 15, 2025 | TAHL CINDY See Remarks | Award | 70,000 | — | Form 4 |
| Jan 15, 2025 | Bressi Jerome Charles See Remarks | Award | 65,000 | — | Form 4 |
| Jan 10, 2025 | Bressi Jerome Charles See Remarks | Sale | 5,980 | $9K | Form 4 |
| Jan 10, 2025 | TAHL CINDY See Remarks | Sale | 5,654 | $9K | Form 4 |
| Jan 10, 2025 | Valamehr Bahram President and CEO · Director | Sale | 8,705 | $13K | Form 4 |
| Dec 20, 2024 | Redmile Group, LLC Director | Purchase | 397,964 | $669K | Form 4 |
| Dec 20, 2024 | Redmile Group, LLC Director | Other | 1,084,936 | $1.82M⚡ | Form 4 |
| Dec 20, 2024 | Redmile Group, LLC Director | Sale | 341,633 | $574K | Form 4 |
| Dec 20, 2024 | Redmile Group, LLC Director | Other | 1,084,936 | $1.82M⚡ | Form 4 |
Valamehr Bahram
President and CEO · Director
Date
May 20
Shares
28,946
Price
$1.88
Value
$54K
Valamehr Bahram
President and CEO · Director
Date
Jan 15
Shares
335,000
Price
—
Value
—
Valamehr Bahram
President and CEO · Director
Date
Jan 9
Shares
5,190
Price
$1.07
Value
$6K
Valamehr Bahram
President and CEO · Director
Date
Aug 4
Shares
14,466
Price
$1.06
Value
$15K
Valamehr Bahram
President and CEO · Director
Date
Jan 10
Shares
8,705
Price
$1.54
Value
$13K
Redmile Group, LLC
Director
Date
Dec 20
Shares
1,084,936
Price
$1.68
Value
$1.82M ⚡
Redmile Group, LLC
Director
Date
Dec 20
Shares
1,084,936
Price
$1.68
Value
$1.82M ⚡
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About FATE insider trading
FATE insider trades
Fate Therapeutics, Inc. (FATE) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including TAHL CINDY (See Remarks), Valamehr Bahram (President and CEO · Director), Redmile Group, LLC (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. FATE insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Fate Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
FATE insider trading · 5 questionsThe insiders of Fate Therapeutics, Inc. (FATE) include executives and directors such as TAHL CINDY (See Remarks), Valamehr Bahram (President and CEO · Director), Redmile Group, LLC (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026